DK165593C - Fremgangsmaade til fremstilling af 6-methylen- delta4-3-ketosteroider - Google Patents
Fremgangsmaade til fremstilling af 6-methylen- delta4-3-ketosteroiderInfo
- Publication number
- DK165593C DK165593C DK050181A DK50181A DK165593C DK 165593 C DK165593 C DK 165593C DK 050181 A DK050181 A DK 050181A DK 50181 A DK50181 A DK 50181A DK 165593 C DK165593 C DK 165593C
- Authority
- DK
- Denmark
- Prior art keywords
- formula
- methylene
- preparing
- steroid
- alkoxy
- Prior art date
Links
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical class O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- AFINAILKDBCXMX-PBHICJAKSA-N (2s,3r)-2-amino-3-hydroxy-n-(4-octylphenyl)butanamide Chemical compound CCCCCCCCC1=CC=C(NC(=O)[C@@H](N)[C@@H](C)O)C=C1 AFINAILKDBCXMX-PBHICJAKSA-N 0.000 abstract 1
- QZLYKIGBANMMBK-UGCZWRCOSA-N 5α-Androstane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 235000019256 formaldehyde Nutrition 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003128 pregnanes Chemical class 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0025—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0044—Alkenyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
- C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3004508A DE3004508C2 (de) | 1980-02-05 | 1980-02-05 | Verfahren zur Herstellung von 6-Methylensteroiden |
| DE3004508 | 1980-02-05 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK50181A DK50181A (da) | 1981-08-06 |
| DK165593B DK165593B (da) | 1992-12-21 |
| DK165593C true DK165593C (da) | 1993-05-03 |
Family
ID=6093992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK050181A DK165593C (da) | 1980-02-05 | 1981-02-05 | Fremgangsmaade til fremstilling af 6-methylen- delta4-3-ketosteroider |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4322349A (en:Method) |
| EP (1) | EP0034115B1 (en:Method) |
| JP (1) | JPS56125399A (en:Method) |
| AT (1) | ATE3717T1 (en:Method) |
| CA (1) | CA1164859A (en:Method) |
| DD (1) | DD155994A5 (en:Method) |
| DE (2) | DE3004508C2 (en:Method) |
| DK (1) | DK165593C (en:Method) |
| HU (1) | HU184376B (en:Method) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8517360D0 (en) * | 1985-07-09 | 1985-08-14 | Erba Farmitalia | Substituted androsta-1,4-diene-3,17-diones |
| GB8721383D0 (en) * | 1987-09-11 | 1987-10-21 | Erba Farmitalia | Preparation of methylene derivatives |
| GB8801697D0 (en) * | 1988-01-26 | 1988-02-24 | Erba Farmitalia | Improvements in synthesis of 6-methylene derivatives of androsta-1 4-diene-3 17-dione |
| US5792758A (en) * | 1995-12-08 | 1998-08-11 | G. D. Searle & Co. | Steroid nitrite ester derivatives useful as anti-inflammatory drugs |
| RU2297423C1 (ru) * | 2006-02-01 | 2007-04-20 | Николай Вадимович Лукашёв | СПОСОБ ПОЛУЧЕНИЯ 6α-МЕТИЛГИДРОКОРТИЗОНА |
| CN100398553C (zh) * | 2006-07-24 | 2008-07-02 | 汪家振 | 游离甲地孕酮的化学合成方法 |
| US20090012321A1 (en) * | 2007-06-06 | 2009-01-08 | Klaus Annen | Process for preparing 17alpha-acetoxy-6-methylenepregn-4-ene-3,20-dione, medroxyprogesterone acetate and megestrol acetate |
| DE102007026636A1 (de) | 2007-06-06 | 2008-12-11 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur Herstellung von 17α-Acetoxy-6-methylenpregn-4-en-3,20-dion, Medroxyprogesteronacetat und Megestrolacetat |
| FR3012452A1 (fr) | 2013-10-28 | 2015-05-01 | Sanofi Sa | Procede de preparation de derives steroidiens |
| RU2663893C1 (ru) * | 2017-07-14 | 2018-08-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Способ получения 6-дегидро-6-метилгидрокортизона или его эфиров из 21-ацетата гидрокортизона |
| CN113583074A (zh) * | 2021-06-28 | 2021-11-02 | 佳尔科生物科技南通有限公司 | 一种6-甲基-17α-羟基黄体酮及其前体的制备新方法 |
| CN114057821B (zh) * | 2021-11-30 | 2022-12-09 | 黑龙江中医药大学 | 用于围绝经期综合征的醋酸甲羟孕酮的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB929983A (en) * | 1960-11-07 | 1963-06-26 | British Drug Houses Ltd | 6-formyl steroids |
| US3095411A (en) * | 1960-11-07 | 1963-06-25 | British Drug Houses Ltd | 3-enol ethers of 6-hydroxymethyl-3-oxo-delta4-steroids and process for their preparation |
| BE656126A (en:Method) * | 1963-11-22 | |||
| GB1078174A (en) * | 1965-07-01 | 1967-08-02 | British Drug Houses Ltd | 6-substituted pregnane compounds |
| BE759143A (fr) * | 1969-11-19 | 1971-05-19 | Upjohn Co | Procede de preparation d'un nouveau compose steroide |
-
1980
- 1980-02-05 DE DE3004508A patent/DE3004508C2/de not_active Expired
-
1981
- 1981-02-03 DD DD81227403A patent/DD155994A5/de not_active IP Right Cessation
- 1981-02-04 AT AT81730012T patent/ATE3717T1/de not_active IP Right Cessation
- 1981-02-04 DE DE8181730012T patent/DE3160396D1/de not_active Expired
- 1981-02-04 EP EP81730012A patent/EP0034115B1/de not_active Expired
- 1981-02-04 HU HU81263A patent/HU184376B/hu not_active IP Right Cessation
- 1981-02-05 CA CA000370152A patent/CA1164859A/en not_active Expired
- 1981-02-05 DK DK050181A patent/DK165593C/da not_active IP Right Cessation
- 1981-02-05 JP JP1509181A patent/JPS56125399A/ja active Granted
- 1981-02-17 US US06/235,240 patent/US4322349A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0034115A2 (de) | 1981-08-19 |
| ATE3717T1 (de) | 1983-06-15 |
| EP0034115A3 (en) | 1981-10-28 |
| US4322349A (en) | 1982-03-30 |
| DE3004508A1 (de) | 1981-08-06 |
| HU184376B (en) | 1984-08-28 |
| JPS56125399A (en) | 1981-10-01 |
| DK165593B (da) | 1992-12-21 |
| CA1164859A (en) | 1984-04-03 |
| DE3004508C2 (de) | 1981-12-10 |
| DE3160396D1 (en) | 1983-07-14 |
| DK50181A (da) | 1981-08-06 |
| JPS6356235B2 (en:Method) | 1988-11-07 |
| DD155994A5 (de) | 1982-07-21 |
| EP0034115B1 (de) | 1983-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK50181A (da) | Fremgangsmaade til fremstilling af 6-methylensteroider | |
| NO171005C (no) | Fremgangsmaate for fremstilling av et vandig flytende preparat | |
| EP0393658A3 (en) | Novel steroid derivatives | |
| ATE39388T1 (de) | Verfahren zur herstellung von truebgasarmen eich- oder kontrollseren. | |
| ATE15646T1 (de) | Verfahren zur herstellung von hydroxy-phenoxyalkancarbons|uren. | |
| ES444442A1 (es) | Un procedimiento para la preparacion de emulsiones en agua en 1,1,2-tricloro-1,2,2-trifluoretano. | |
| ATE43339T1 (de) | Verfahren zur herstellung von optisch aktiven hydrochinonderivaten sowie von d-alphatocopherol. | |
| IL67023A (en) | Substituted thiazolidinyl esters of phosphoric and sulfuric acid | |
| DK1047658T3 (da) | Fremgangsmåde til fremstilling af alkoxylerede dimerfedtsyrer | |
| DK112082A (da) | Fremgangsmaade til fremstilling af polyalkylindaner | |
| JPS5225740A (en) | Preparation of o-acyl-amidinophenols or acid addition salts thereof | |
| JPS55142068A (en) | Adhesive composition | |
| KR830005089A (ko) | 퀴논 화합물의 제조방법 | |
| ATE554T1 (de) | Verfahren zur herstellung von 4-amino-diphenylaminen. | |
| EP0107364A3 (en) | 7-anilinoisoquinoline-5,8-quinones | |
| JPS5285163A (en) | Preparation of malenimide derivatives | |
| DE68910931D1 (de) | Verfahren zur Herstellung von Propionsäurederivaten. | |
| IN170286B (en:Method) | ||
| JPS5246080A (en) | Preparation of pyridinecarbonyl aminoalkyl thiols | |
| GB1385596A (en) | Anthanthrene derivatives and a method of producing same | |
| JPS5355344A (en) | Pressure-sensitive adhesive | |
| FR2254349A2 (en) | 1'-(2-Hydroxyethyl)-1'-demethyl-clindamycin 2-acylates - useful as antibacterials | |
| SU1743164A1 (ru) | Способ получения 2,2-диметил-2-(5',5'-диметил-1',3'-диоксанил)этилциклогексилового эфира | |
| ES2077475T3 (es) | Nuevo procedimiento de preparacion de un compuesto esteroide delta 9(11). | |
| JPS5788200A (en) | Synthetic intermediate of corticoids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |